Table 1. Clinical characteristics of the 78 enrolled patients.
Clinical feature | Overall series n. (%) | Prospective cohort n. (%) | Retrospective cohort n. (%) | Statistical significance* |
---|---|---|---|---|
Patients | 78 | 29 | 49 | |
Age (years)** | 47 (18-79) | 49 (20-68) | 46 (18-79) | p=0.460 |
Sex | p=0.351 | |||
M | 46 (59%) | 15 (52%) | 31 (63%) | |
F | 32 (41%) | 14 (48%) | 18 (27%) | |
Sokal risk score | p=0.542 | |||
Low | 34 (44%) | 11 (38%) | 23 (47%) | |
Intermediate | 29 (37%) | 12 (42%) | 17 (34%) | |
High | 15 (19%) | 6 (20%) | 9 (19%) | |
Eutos risk score | p=0.301 | |||
Low | 40 (51%) | 11 (38%) | 29 (59%) | |
High | 27 (35%) | 11 (38%) | 16 (33%) | |
N/A | 11 (14%) | 7 (24%) | 4 (8%) | |
Hasford risk score | p=0.054 | |||
Low | 40 (51%) | 11 (38%) | 29 (59%) | |
Intermediate | 26 (34%) | 14 (48%) | 12 (25%) | |
High | 12 (15%) | 4 (14%) | 8 (16%) |
Note: *, Students’ t test; **, values are expressed as median (min-max range)